

Other version: https://linkinghub.elsevier.com/retrieve/pii/S0165993620301916
![]() |
Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins |
|
Authors | ||
Published in | Trends in Analytical Chemistry. 2020, vol. 130, p. 115962 | |
Abstract | Reversed-phase liquid chromatography (RPLC) is one of the most widely used chromatographic approaches for the characterization of therapeutic proteins because it is able to answer several analytical queries and allow the fine characterization of the structural heterogeneity of these drugs. However, some issues may possibly occur when analysing therapeutic proteins by RPLC-MS, such as severe band broadening and peak tailing, strong adsorption, possible protein denaturation/degradation, limited MS sensitivity and poor chromatographic selectivity. The present review focuses on the latest advances in RPLC that have been adopted to overcome these issues, including the application of cutting-edge chromatographic conditions, alternative mobile phase compositions and critical discussions on recently commercialized bioinert instruments and RPLC stationary phases. | |
Keywords | Reversed-phase liquid chromatography (RPLC) — Therapeutic proteins — Mass spectrometry | |
Identifiers | ||
Full text |
![]() ![]() Other version: https://linkinghub.elsevier.com/retrieve/pii/S0165993620301916 |
|
Structures | ||
Research group | Sciences analytiques | |
Citation (ISO format) | D'ATRI, Valentina et al. Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins. In: Trends in Analytical Chemistry, 2020, vol. 130, p. 115962. doi: 10.1016/j.trac.2020.115962 https://archive-ouverte.unige.ch/unige:144963 |